ResMed, a leading global producer of CPAP machines and masks for sleep apnea, has acquired Somnoware, a US-based provider of sleep and respiratory care diagnostics software. The acquisition will integrate Somnoware into ResMed’s Sleep & Respiratory Care business, while maintaining Somnoware’s open platform for viewing test results and facilitating faster treatment for diagnosed patients. Financial details of the acquisition were not disclosed.
What You Should Know:
- ResMed, the #1 global producer of CPAP machines and masks to treat sleep apnea acquires Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Financial details of the acquisition were not disclosed.
- Somnoware software streamlines the processes of physicians and sleep labs for diagnosing and evaluating a patient’s sleep and respiratory care test results, ordering treatment equipment, setting up appointments, tracking therapy compliance, and electronically providing this information directly into a patient’s electronic health record.
- As part of the acquisition, Somnoware will retain all staff and be integrated into ResMed’s Sleep & Respiratory Care business. Somnoware platform will remain an open platform to enable sleep labs, pulmonary function testing facilities, and physicians to view results from various testing solutions and help diagnosed patients get onto the treatment they need faster.
Source: HitConsultant
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
